"Zumatek Incorporated - Product Pipeline Analysis" Now Available at Fast Market Research
Zumatek Incorporated (Zumatek) is a developer of imaging technologies to treat breast cancer. The company carries out pilot patient trial, R&D, and commercialization stages. The company's ZumaTek x-ray CT scanner help to identify tumors in a patient's breast. Zumatek along with the partnership with the University of North Carolina Cancer Hospital started a pilot clinical trial in 2011. The company uses x-ray beam spectral filtration and digital flat-panel detector technology which helps physicians to identify breast cancer before a tumor...
View full press release